If eligible, youll receive a once-weekly GLP-1 injection as part of your personalized weight loss plan
,
What This Means for Patients For patients already on the Zepbound Self Pay Journey Program, the price reduction will make it easier to stay on their treatment plan
In the SUSTAIN-6 clinical trial, the incidence of pancreatic cancer was 0% and 0.1% with 0.5 mg and 1 mg semaglutide doses, respectively, compared to 0.2% with the placebo
Weight Regain: Non-surgical methods often lead to initial weight loss, but many individuals regain the weight within five years
The medication not only supports significant weight loss but also helps mitigate the risks of developing serious conditions like diabetes, heart disease, and hypertension, which can lead to substantial healthcare costs over time